Auris Medical to Present at the Jefferies 2016 Healthcare Conference on Thursday, June 9
June 02 2016 - 8:03AM
Auris Medical Holding AG (NASDAQ:EARS), a clinical-stage company
dedicated to developing therapeutics that address important unmet
medical needs in otolaryngology, today announced that Thomas Meyer,
PhD, Chairman and Chief Executive Officer, will present at the
Jefferies 2016 Healthcare Conference in New York City on Thursday,
June 9, 2016, at 3:00 pm EDT. A live webcast of the event will be
available through the Events and Presentations page in the
Investors section of the Auris Medical website at
www.aurismedical.com and a replay of the presentation will be
available following the event.
About Auris Medical
Auris Medical is a Swiss biopharmaceutical
company dedicated to developing therapeutics that address important
unmet medical needs in otolaryngology. The Company is currently
focusing on the development of treatments for acute inner ear
tinnitus (AM-101) and for acute inner ear hearing loss (AM-111) by
way of intratympanic injection with biocompatible gel formulations.
In addition, Auris Medical is pursuing early-stage research and
development projects. The Company was founded in 2003 and is
headquartered in Zug, Switzerland. The shares of the parent company
Auris Medical Holding AG trade on the NASDAQ Global Market under
the symbol "EARS."
Contact: Cindy McGee, Head of Investor Relations
and Corporate Communications, +41 61 201 1350,
investors@aurismedical.com
HUG#2016970
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Oct 2023 to Oct 2024